Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Millennium Biotechnologies, a wholly owned subsidiary of Millennium Biotechnologies Group, has reported that it will receive $600,000 in funding pursuant to the terms of a one year product development agreement with Provider Services of Cleveland, Ohio.
Subscribe to our email newsletter
Mark Mirken, president and COO of Millennium Biotechnologies, said: “Our agreement will allow us to use Millennium’s extensive clinical experience and success in the cancer and HIV channels and apply that experience to the nutritional challenges in the Long Term Care channel.”